Cargando…
Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
FKB327 was approved by the European Medicines Agency as a biosimilar to European‐authorized adalimumab (Humira(®); AbbVie Inc). Adalimumab is a monoclonal antibody, binding and inhibiting tumor necrosis factor (TNF)‐α with use indicated for several immune‐mediated, chronic, and inflammatory disorder...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272391/ https://www.ncbi.nlm.nih.gov/pubmed/32500668 http://dx.doi.org/10.1002/prp2.604 |